Tamilarasu Naveena, Narayanaswamy Radhakrishnan, Prabhakaran Vasantha-Srinivasan
Biochemistry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, IND.
Bioinformatics, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, IND.
Cureus. 2024 Feb 3;16(2):e53494. doi: 10.7759/cureus.53494. eCollection 2024 Feb.
Background (Licorice) has been known for its various biological activities. In the current investigation, we aimed to evaluate 11 (10 natural and one synthetic) selected constituents of as potent modulatory agents of human superoxide dismutase (hSOD), human phosphodiesterase-9 (hPDE 9) and human dipeptidyl peptidase-4 (hDPP 4) using method. Methodology The 11 selected constituents of (Licorice) were investigated on the docking behaviour of hSOD, hPDE 9 and hDPP 4 by using the PatchDock method. In addition to docking, toxicity analysis was also carried out using the pkCSM free online server (University of Melbourne, Melbourne, AUS). Results Toxicity analysis has shown that four ligands (36%) of (Licorice) are predicted to have human ether-a-go-go-related gene-2 (hERG 2) inhibition activity. The docking analysis showed that glabridin (-224.13 kcal/mol) has shown the highest atomic contact binding energy with the hSOD enzyme, whereas carbenoxolone has shown the maximum atomic contact binding energy with both the hPDE 9 and hDPP 4 enzymes (-239.57 and -173.50 kcal/mol) respectively. Conclusion Thus the present finding provides new information about 11 selected ligands of (Licorice) as potent modulatory agents of hSOD, hPDE 9 and hDPP 4.
背景 甘草因其多种生物活性而闻名。在当前的研究中,我们旨在使用[具体方法]评估甘草中11种(10种天然成分和1种合成成分)选定成分作为人类超氧化物歧化酶(hSOD)、人类磷酸二酯酶-9(hPDE 9)和人类二肽基肽酶-4(hDPP 4)的有效调节剂。方法 采用PatchDock方法研究了甘草中11种选定成分对hSOD、hPDE 9和hDPP 4的对接行为。除对接外,还使用免费在线服务器pkCSM(澳大利亚墨尔本大学)进行了毒性分析。结果 毒性分析表明,甘草的四种配体(36%)预计具有人类醚 - 去极化相关基因-2(hERG 2)抑制活性。对接分析表明,光甘草定(-224.13千卡/摩尔)与hSOD酶显示出最高的原子接触结合能,而甘珀酸分别与hPDE 9和hDPP 4酶显示出最大的原子接触结合能(-239.57和-173.50千卡/摩尔)。结论 因此,本研究结果提供了关于甘草中11种选定配体作为hSOD、hPDE 9和hDPP 4有效调节剂的新信息。